Stockscreener 앱 받기
6.115
1.24%
0.075
시간 외 거래:
6.15
0.035
+0.57%
전일 마감가:
$6.04
열려 있는:
$6.04
하루 거래량:
74,329
Relative Volume:
1.11
시가총액:
$175.28M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-8.73%
1개월 성능:
-7.77%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$5.844
$6.15
1주일 범위
$5.82
$6.66
52주 변동 폭
$2.33
$8.51
Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile
명칭
Insight Molecular Diagnostics Inc
전화
949-409-7600
주소
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE
IMDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMDX
Insight Molecular Diagnostics Inc
|
6.115 | 173.13M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-28 | 개시 | Lake Street | Buy |
| 2022-05-24 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-03-17 | 재개 | Needham | Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | 개시 | BTIG Research | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | 재확인 | The Benchmark Company | Speculative Buy |
| 2020-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | 개시 | Needham | Buy |
| 2019-02-13 | 개시 | Piper Jaffray | Overweight |
| 2019-01-29 | 업그레이드 | Janney | Neutral → Buy |
| 2018-12-19 | 재개 | Lake Street | Buy |
모두보기
Insight Molecular Diagnostics Inc 주식(IMDX)의 최신 뉴스
Insight Molecular Diagnostics (IMDX) Price Target Increased by 29.23% to 7.14 - MSN
Will Insight Molecular Diagnostics Inc. (7OC0) stock remain on Wall Street radarJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com
Will Insight Molecular Diagnostics Inc. (7OC0) stock gain from green policiesQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Can Insight Molecular Diagnostics Inc. (7OC0) stock sustain institutional flowsJuly 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Why Insight Molecular Diagnostics Inc. (7OC0) stock stays resilient2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Published on: 2025-11-19 17:04:49 - newser.com
Published on: 2025-11-19 13:52:26 - newser.com
Published on: 2025-11-19 13:17:14 - newser.com
Is Insight Molecular Diagnostics Inc. (7OC0) stock worth holding before Fed meetingMarket Volume Report & Capital Efficient Trade Techniques - newser.com
How Insight Molecular Diagnostics Inc. (7OC0) stock trades under stagflation2025 Sector Review & Precise Swing Trade Alerts - newser.com
Is Insight Molecular Diagnostics Inc. (7OC0) stock a top pick for value investorsQuarterly Market Review & Free High Return Stock Watch Alerts - newser.com
This Biotech Stock Is Up 158% in a Year. What’s Driving It Higher? - MSN
Insight Molecular Diagnostics Inc.Common Stock (NQ: IMDX - Markets Financial Content
Insight Molecular Diagnostics Advances Kidney Transplant Monitoring with New Study - MSN
Insight Molecular Diagnostics: GraftAssureDX FDA Submission Warrants Hold Rating (IMDX) - Seeking Alpha
Insight Molecular Diagnostics Inc (IMDX) 재무 분석
Insight Molecular Diagnostics Inc (IMDX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.35%
1.41%
자본화:
|
볼륨(24시간):